Business
TerrAscend Announces the Appointment of Ed Schutter to its Board of Directors
TerrAscend Announces the Appointment of Ed Schutter to its Board of Directors C...
About this update from Terrascend Corp.
[{"type":"text","content":"\n \n \n \n TerrAscend Announces the Appointment of Ed Schutter to its Board of Directors\n \n \n /* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n \n \n \n \n \n \n Canada NewsWire\n \n \n NEW YORK and TORONTO, Nov. 2, 2020\n \n \n \n \n \n NEW YORK\n \n and\n \n TORONTO\n \n ,\n \n Nov. 2, 2020\n \n /CNW/ - TerrAscend Corp. (\"TerrAscend\" or the \"Company\") (CSE: TER) (OTCQX: TRSSF), a leading North American cannabis operator, today announced the appointment of\n \n Ed Schutter\n \n to its Board of Directors.\n \n \n Mr. Schutter is a seasoned executive with over thirty years of pharmaceutical industry experience. He currently serves as Chief Executive Officer of Arbor Pharmaceuticals (\"Arbor\"), an\n \n Atlanta, Georgia\n \n based specialty pharmaceutical company which markets prescription products for the cardiovascular, neuroscience and orphan/hospital markets. Arbor also has several branded prescription products in late stage development.\n \n \n \"We are thrilled to welcome Ed to our Board at such a pivotal time in our Company's growth,\" said\n \n Jason Ackerman\n \n , Chief Executive Officer and Executive Chairman of TerrAscend. \"Ed brings a tremendous amount of relevant Board experience and new ideas to the table. His experience in the U.S. and global pharmaceutical industry will serve TerrAscend well as we continue to build scale and accelerate our growth.\"\n \n \n \n Jason Wild\n \n , Chairman of TerrAscend, added, \"As Chairman of Arbor, I have had the pleasure of working with Ed for over 10 years. He is bright, passionate, honest, and genuinely cares about the wellbeing of Arbor's employees and patients. He has been a source of trusted advice to me, as it relates to TerrAscend over the last three years, and I am thrilled that he has joined our Board. His M&A experience will be particularly useful to us as we continue to grow.\"\n \n \n Prior to joining Arbor, Ed served as President of Sciele (Shionogi) Pharmaceuticals. Prior to Sciele, he served as VP of Global Business development at Solvay Pharmaceuticals based in\n \n Basel, Switzerland\n \n . He has also ...